An investigation of the subacute effects of ecstasy on neuropsychological performance, sleep and mood in regular ecstasy users

Journal of Psychopharmacology

Volumn 24, Issue 2, 2010, Pages 175-185

  Pirona, A ^a   Morgan, M J ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

Cognition; Ecstasy; MDMA; Mood; Sleep; Subacute

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; COGNITION; CONTROLLED STUDY; DECISION MAKING; DEPRESSION; FEMALE; HUMAN; IMPULSIVENESS; INTELLIGENCE QUOTIENT; MALE; MOOD; NEUROPSYCHIATRY; PERSONALITY; PRIORITY JOURNAL; PSYCHOMETRY; SLEEP; SLEEP DEPRIVATION; SLEEP DISORDER; SUBSTANCE ABUSE; WORKING MEMORY;

ADULT; AFFECT; AGE FACTORS; DECISION MAKING; FEMALE; HALLUCINOGENS; HUMANS; INTELLIGENCE; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEUROPSYCHOLOGICAL TESTS; PERSONALITY; PSYCHOMETRICS; QUESTIONNAIRES; SLEEP; SUBSTANCE-RELATED DISORDERS; TIME FACTORS; YOUNG ADULT;

EID: 76649130536     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881109102780     Document Type: Article

References (38)

1. Allen, RP, McCann, UD, Ricaurte, GA (1993) Persistent effects of (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on human sleep. Sleep 16: 560-564.
2. Bechara, A., Damasio, AR, Damasio, H., Anderson, SW (1994) Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 50: 7-15.
3. Beck, AT, Ward, CH, Mendelson, M., Mock, J., Erbaugh, J. (1961) An inventory for measuring depression. Arch Gen Psychiatry 4: 561-571.
4. Cairns, E., Cammock, T. (1978) Development of a more reliable version of the Matching Familiar Figures Test. Dev Psychol 13: 555-560.
5. Cottler, LB, Womack, SB, Compton, WM, Ben-Abdallah, A. (2001) Ecstasy abuse and dependence among adolescents and young adults: applicability and reliability of DSM-IV criteria. Hum Psychopharmacol 16: 599-606.
6. Curran, HV, Travill, RA (1997) Mood and cognitive effects of 3,4-methylenedioxymeth-amphetamine (MDMA, "Ecstasy"). weekend "high" followed by mid-week low. Addiction 92: 821-831.
7. Curran, HV, Rees, H., Hoare, T., Hoshi, R., Bond, A. (2004) Empathy and aggression: two faces of ecstasy? A study of interpretative cognitive bias and mood change in ecstasy users. Psychopharmacology 173: 425-433.
8. Davison, D., Parrott, AC (1997) Ecstasy (MDMA) in recreational users: Self-reported psychological and physiological effects. Hum Psychopharmacol Clin Exp 12: 221-226.
9. de la Torre, R., Farre, M., Mathuna, BO, Roset, PN, Pizarro, N., Segura, M., et al. (2005) MDMA (ecstasy) pharmacokinetics in a CYP2D6 poor metaboliser and in nine CYP2D6 extensive metabolisers. Eur J Clin Pharmacol 61: 551-554.
10. Durmer, JS, Dinges, DF (2005) Neurocognitive consequences of sleep deprivation. Semin Neurol 25: 117-129.
11. Groth-Marnat, G. (1990) The Handbook of Psychological Assessment (2 nd ed.). New York: John Wiley & Sons.
12. Hoshi, R., Bisla, J., Curran, HV (2004) The acute and sub-acute effects of ecstasy (MDMA) on processing of facial expressions: preliminary findings. Drug Alcohol Depend 76: 297-304.
13. Huxster, JK, Pirona, A., Morgan, MJ (2006) The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans. J Psychopharmacol 20: 281-290.
14. Liechti, ME, Vollenweider, FX (2000 a) The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine (Ecstasy) in healthy volunteers. J Psychopharmacol 14: 269-274.
15. Liechti, ME, Vollenweider, FX (2000 b) Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans. Eur Neuropsychopharmacol 10: 289-295.
16. Liechti, ME, Baumann, C., Gamma, A., Vollenweider, FX (2000 a) Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram. Neuropsychopharmacology 22: 513-521.
17. Liechti, ME, Saur, MR, Gamma, A., Hell, D., Vollenweider, FX (2000 b) Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans. Neuropsychopharmacology 23: 396-404.
18. Morgan, MJ (1998 a) Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity. Neuropsychopharmacol 19: 252-264.
19. Morgan, MJ (1998 b) Lasting psychological sequelae of recreational use of MDMA ("Ecstasy"). controlled studies in humans ? J Psychopharmacol 12: 101-102.
20. Morgan, MJ (1999) Memory deficits associated with recreational use of "ecstasy" (MDMA). Psychopharmacology 141: 30-36.
21. Morgan, MJ (2000) Ecstasy (MDMA). a review of its possible persistent psychological effects. Psychopharmacology 152: 230-248.
22. Morgan, MJ, Impallomeni, LC, Pirona, A., Rogers, RD (2006) Elevated impulsivity and impaired decision-making in abstinent ecstasy (MDMA) users compared to polydrug and drug-na»ve controls. Neuropsychopharmacology 31: 1562-1573.
23. Morgan, MJ, McFie, L., Fleetwood, H., Robinson, JA (2002) Ecstasy (MDMA). are the psychological problems associated with its use reversed by prolonged abstinence ? Psychopharmacology 159: 294-303.
24. Nelson, HE (1982) National Adult Reading Test. Nelson Publishing Company Ltd.
25. Parrott, AC, Lasky, J. (1998) Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance. Psychopharmacology 139: 261-268.
26. Parrott, AC (2004) Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity. Psychopharmacology 173: 234-241.
27. Parrott, AC (2005) Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy. J Psychopharmacol 19: 71-83.
28. Peterson, JB, Pihl, OP, Higgins, D., Lee, A. (1996) Neurocognitive Battery ( NCB ).
29. Solowij, N., Hall, W., Lee, N. (1992) Recreational MDMA use in Sydney: A profile of "Ecstasy" users and their experiences with the drug. Br J Addiction 87: 1161-1172.
30. Sumnall, HR, Cole, JC (2005) Self-reported depressive symptomatology in community samples of polysubstance misusers who report Ecstasy use: a meta-analysis. J Psychopharmacol. 19: 84-92.
31. Sumnall, HR, Cole, JC, Jerome, L. (2006) The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy. J. Psychopharmacol. 20: 670-682.
32. Topp, L., Hando, J., Dillon, P., Roche, A., Solowij, N. (1999) Ecstasy use in Australia: patterns of use and associated harm. Drug Alcohol Depend 55: 105-115.
33. Tsuno, N., Besset, A., Ritchie, K. (2005) Sleep and depression. J Clin Psychiatry 66: 1254-1269.
34. Verheyden, SL, Hadfield, J., Calin, T., Curran, HV (2002) Sub-acute effects of MDMA (+/-3,4-ethylenedioxymethamphetamine, "ecstasy") on mood: evidence of gender differences. Psychopharmacology 161: 23-31.
35. Verheyden, SL, Henry, JA, Curran, HV (2003) Acute, sub-acute and long-term subjective consequences of ecstasy (MDMA) consumption in 430 regular users. Hum Psychopharmacol 18: 507-517.
36. Vollenweider, FX, Gamma, A., Liechti, M., Huber, T. (1998) Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naive healthy volunteers. Neuropsychopharmacology 19: 241-251.
37. Wilson, B., Cockburn, J., Baddeley, A. (1985) The Rivermead Behavioural Memory Test. Reading, UK: Thames Valley Text Co.
38. Winstock, AR, Griffiths, P., Stewart, D. (2001) Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK. Drug Alcohol Depend 64: 9-17.